Ratio of von willebrand factor propeptide to adamts13 is associated with severity of sepsis

Shock

Volumn 39, Issue 5, 2013, Pages 409-414

  Fukushima, Hidetada ^a   Nishio, Kenji ^a   Asai, Hideki ^a   Watanabe, Tomoo ^a   Seki, Tadahiko ^a   Matsui, Hideto ^a   Sugimoto, Mitsuhiko ^a   Matsumoto, Masanori ^a   Fujimura, Yoshihiro ^a   Okuchi, Kazuo ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAMTS13; multiple organ dysfunction; Sepsis; von Willebrand factor propeptide

Indexed keywords

CREATININE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; ADULT; AGED; APACHE; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HUMAN; MALE; ORGAN DYSFUNCTION SCORE; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; THROMBOCYTE COUNT;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SEPSIS; SHOCK, SEPTIC; VON WILLEBRAND FACTOR;

EID: 84876850879     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182908ea7     Document Type: Article

References (35)

1. Dellinger RP: Inflammation and coagulation: implications for the septic patient. Clin Infect Dis 36(10):1259-1265, 2003. (Pubitemid 36629935)
2. Vallet B: Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care 7(2):130-138, 2003. (Pubitemid 36432671)
3. Sadler JE: Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67:395-424, 1998. (Pubitemid 28411134)
4. van Mourik J.A., Boertjes R, Huisveld I.A., Fijnvandraat K., Pajkrt D, van Genderen PJ, Fijnheer R: Von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation. Blood 94(1):179-185, 1999. (Pubitemid 29300147)
5. Borchiellini A, Fijnvandraat K, ten Cate JW, Pajkrt D, van Deventer SJ, Pasterkamp G, Meijer-Huizinga F, Zwart-Huinink L, Voorberg J, et al.: Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood 88(8):2951-2958, 1996. (Pubitemid 26357375)
6. Salat C, Boekstegers P, Holler E., Werdan K, Reinhardt B, Fateh-Moghadam S, Pihusch R., Kaul M, Beinert T, Hiller E: Hemostatic parameters in sepsis patients treated with antiYTNF alphaYmonoclonal antibodies. Shock 6(4): 233-237, 1996. (Pubitemid 126727767)
7. Dong JF, Moake JL, Nolasco L, Bernardo A., Arceneaux W, Shrimpton CN, Schade AJ, McIntire L.V., Fujikawa K., Lopez JA: ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 100(12):4033-4039, 2002. (Pubitemid 35396870)
8. Chauhan AK, Motto DG, Lamb C.B., Bergmeier W., Dockal M, Plaimauer B, Scheiflinger F., Ginsburg D, Wagner DD: Systemic antithrombotic effects of ADAMTS13. J Exp Med 203(3):767-776, 2006.
9. Bernardo A, Ball C, Nolasco L., Choi H, Moake JL, Dong JF: Platelets adhered to endothelial cellYbound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J Thromb Haemost 3(3):562-570, 2005. (Pubitemid 41632882)
10. Moake JL: Von Willebrand factor, ADAMTS-13, and thrombotic thrombocy-topenic purpura. Semin Hematol 41(1):4-14, 2004. (Pubitemid 38057780)
11. Ono T, Mimuro J, Madoiwa S., Soejima K, Kashiwakura Y, Ishiwata A., Takano K, Ohmori T, Sakata Y: Severe secondary deficiency of von Willebrand factorYcleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 107(2):528-534, 2006. (Pubitemid 43076375)
12. Moake JL, Chow TW: Thrombotic thrombocytopenic purpura: understanding a disease no longer rare. Am J Med Sci 316(2):105-119, 1998. (Pubitemid 28371238)
13. Martin K, Borgel D, Lerolle N., Feys HB, Trinquart L, Vanhoorelbeke K, Deckmyn H., Legendre P, Diehl JL, Baruch D: Decreased ADAMTS-13 (a disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 35(10):2375-2382, 2007. (Pubitemid 47476237)
14. Bockmeyer CL, Claus RA, Budde U, Kentouche K., Schneppenheim R, Losche W, Reinhart K., Brunkhorst FM: Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor. Haematologica 93(1):137-140, 2008. (Pubitemid 351156164)
15. Claus RA, Bockmeyer CL, Budde U, Kentouche K., Sossdorf M, Hilberg T, Schneppenheim R., Reinhart K, Bauer M, Brunkhorst FM, et al.: Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thromb Haemost 101(2):239-247, 2009.
16. Rieger M, Ferrari S, Kremer Hovinga JA, Konetschny C, Herzog A, Koller L., Weber A, Remuzzi G, Dockal M, Plaimauer B, et al.: Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA). Thromb Haemost 95(2): 212-220, 2006.
17. Nguyen TC, Han YY, Kiss J.E., Hall MW, Hassett AC, Jaffe R, Orr R.A., Janosky J., Carcillo JA: Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 36(10):2878-2887, 2008.
18. Bone RC, Balk RA, Cerra F.B., Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101(6):1644-1655, 1992.
19. Johnson CA, Levey AS, Coresh J, Levin A., Lau J, Eknoyan G: Clinical practice guidelines for chronic kidney disease in adults: part II. Am Fam Physician 70(6):1091-1097, 2004.
20. Durand F, Valla D: Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 42(Suppl 1):S100-S107, 2005. (Pubitemid 40364609)
21. Knaus WA, Draper EA, Wagner D.P., Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 13(10):818-829, 1985. (Pubitemid 15250137)
22. Vincent JL, Moreno R, Takala J., Willatts S, De Mendonca A, Bruining H, Reinhart C.K., Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22(7):707-710, 1996. (Pubitemid 26254283)
23. Molitoris BA, Levin A, Warnock D.G., Joannidis M., Mehta RL, Kellum JA, Ronco C, Shah S.V., and Acute Kidney Injury Network Working Group: Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol 3(8):439-442, 2007. (Pubitemid 47123586)
24. Kremer Hovinga J.A., Zeerleder S, Kessler P., Romani de Wit T, van Mourik JA, Hack CE, ten Cate H, Reitsma PH, Wuillemin WA, Lammle B: ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost 5(11):2284-2290, 2007. (Pubitemid 47617882)
25. Crawley JT, Lam JK, Rance J.B., Mollica LR, O'Donnell JS, Lane DA: Pro-teolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 105(3): 1085-1093, 2005. (Pubitemid 40170879)
26. Reiter RA, Knobl P, Varadi K., Turecek PL: Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin. Blood 101(3):946-948, 2003. (Pubitemid 36139364)
27. Reiter RA, Varadi K, Turecek P.L., Jilma B., Knobl P: Changes in ADAMTS13 (von-Willebrand-factorYcleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost 93(3):554-558, 2005. (Pubitemid 40392546)
28. Metcalf DJ, Nightingale TD, Zenner H.L., Lui-Roberts WW, Cutler DF: Formation and function of Weibel-Palade bodies. J Cell Sci 121(Pt 1):19-27, 2008. (Pubitemid 351265699)
29. Bockmeyer CL, Reuken PA, Simon T.P., Budde U., Losche W, Bauer M, Birschmann I., Becker JU, Marx G, Claus RA: ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus deposition. Thromb Haemost 105(1):145-153, 2011.
30. Kayal S, Jais JP, Aguini N, Chaudiere J., Labrousse J: Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 157(3 Pt 1): 776-784, 1998.
31. van Mourik J.A., Romani de Wit T: Von Willebrand factor propeptide in vascular disorders. Thromb Haemost 86(1):164-171, 2001. (Pubitemid 32663949)
32. Shida Y, Nishio K, Sugimoto M., Mizuno T, Hamada M, Kato S., Matsumoto M, Okuchi K, Fujimura Y, Yoshioka A: Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions. Blood 111(3):1295-1298, 2008. (Pubitemid 351213413)
33. Doi M, Matsui H, Takeda Y., Saito Y, Takeda M, Matsunari Y., Nishio K, Shima M, Banno F, Akiyama M, et al.: ADAMTS13 safeguards the myocardium in a mouse model of acute myocardial infarction. Thromb Haemost 108(6):1236-1238, 2012.
34. Fujioka M, Hayakawa K, Mishima K., Kunizawa A, Irie K, Higuchi S., Nakano T, Muroi C, Fukushima H, Sugimoto M, et al. ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion. Blood 115(8):1650-1653, 2010.
35. Fujioka M, Nakano T, Hayakawa K., Irie K, Akitake Y, Sakamoto Y., Mishima K, Muroi C, Yonekawa Y, Banno F, et al. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. Neurol Sci 33(5):1107-1115, 2012.